↓ Skip to main content

EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R

Overview of attention for article published in Frontiers in Medicine, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy
1 policy source
twitter
10 X users

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D
Published in
Frontiers in Medicine, October 2018
DOI 10.3389/fmed.2018.00270
Pubmed ID
Authors

Kay Warner, Wolf See, David Haerry, Ingrid Klingmann, Amy Hunter, Matthew May

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 90 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 17%
Student > Ph. D. Student 13 14%
Researcher 7 8%
Student > Bachelor 6 7%
Other 5 6%
Other 7 8%
Unknown 37 41%
Readers by discipline Count As %
Medicine and Dentistry 14 16%
Pharmacology, Toxicology and Pharmaceutical Science 11 12%
Biochemistry, Genetics and Molecular Biology 6 7%
Business, Management and Accounting 6 7%
Social Sciences 4 4%
Other 11 12%
Unknown 38 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2020.
All research outputs
#3,241,075
of 25,295,968 outputs
Outputs from Frontiers in Medicine
#928
of 7,105 outputs
Outputs of similar age
#63,222
of 353,248 outputs
Outputs of similar age from Frontiers in Medicine
#20
of 91 outputs
Altmetric has tracked 25,295,968 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,105 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,248 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.